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ABSTRACT: The major peanut allergen Ara h 1 is an easily digestible protein under physiological conditions. The present study
revealed that pepsin digestion products of Ara h 1 retained the sensitizing potential in a Brown Norway rat model, while this
sensitizing capacity was lost by separating the digest into fractions by gel permeation chromatography. Protein chemical analysis
showed that the peptide composition as well as the aggregation profiles of the fractions of Ara h 1 digest differed from that of the
whole pool. These results indicate that the sensitizing capacity of digested Ara h 1 is a consequence of the peptides being in an
aggregated state resembling the intact molecule or that most peptides of the digests need to be present in the same solution,
having a synergistic or adjuvant effect and thereby augmenting the immune response against other peptides.
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■ INTRODUCTION
Food allergy most often involves an allergen-specific IgE
antibody-mediated immunologic response. It is an adverse
reaction to an otherwise harmless food or food component that
involves an abnormal response of the immune system to
specific food proteins. One of the major unanswered questions
in food allergy research is what makes a protein a food allergen.
Yet, no definite answer to this exists. However, one of the
hypotheses has been that for a protein to be a food allergen, it
must survive the digestion process through the gastrointestinal
tract, to reach the immune system as an intact protein or as
large peptide fragments.1,2 The first systematic assessment of
food allergen digestibility was conducted in 1996 by Astwood
et al.3 They showed that in general food allergens were resistant
to pepsin digestion, whereas nonallergenic proteins were more
easily digested. Since this, several studies examining the
correlation between resistance to digestion and allergenicity
have been made, where the correlation between stability
and allergenicity was less clear.4−10 However, it may still be
reasonable to think that proteins being resistant or at least
partially resistant to digestion have an increased probability of
reaching the intestinal mucosa in a form that is sufficiently
immunologically active to sensitize the mucosal immune system
and be sufficient in size to retain the ability to cross-link two
IgE molecules and thereby elicit an allergic reaction. The
stability to digestion is for those reasons also recommended for
use in the safety assessment of newly introduced proteins in
genetically modified foods based on a decision tree or a weight
of evidence approach, which includes, among a variety of tests,
the assessment of resistance to digestion by pepsin.11−13 How-
ever, while pepsin stability as a part of an allergenicity assess-
ment would still seem reasonable for the purpose of safety
evaluation of most food proteins, we now know that for some
allergenic proteins, this approach would be misleading. The milk
allergen β-casein (Bos d 8)7,14,15 as well as the peanut allergen
Ara h 19,10 have several times been shown to be easily digestible
food allergens.
Peanut allergy is one of the most common and serious types
of IgE-mediated food allergies in terms of persistency and
severity16,17 and seems to be an increasing problem in the
western world.18,19 The peanut protein Ara h 1, which is a
major allergen,20,21 is a 7S globulin protein belonging to the
cupin superfamily of allergens.22 Ara h 1 is a homotrimeric
protein, consisting of 63.5 kDa large subunits,20 held together
by hydrophobic interactions between amino acids at
monomer−monomer contact points.23,24 Ara h 1 is a readily
digestible allergen, being digested to small peptide fragments by
gastroduodenal digestion.9,10 Even though Ara h 1 is a labile
protein, Eiwegger et al.9 and Bøgh et al.10 showed that the
digestion products of Ara h 1 retain allergenic potential, being
able to sensitize as well as elicit allergic reactions. These studies
indicated that aggregation of peptides may play a major role in
maintaining allergenic activity. Epitope mapping studies of this
protein have suggested both linear21 and conformational25 IgE-
binding epitopes, at least some of which are able to survive the
digestion process.10,26
Peptides need to have a certain size to be allergenic, but the
exact lower molecular weight (MW) size limit is not known.
Yet, many suggestions for such a lower MW size limit have
been presented,11,27−31 and the general view appears to be that
peptides need to be approximately 3.5 kDa to contain sen-
sitizing and eliciting allergenic capacity. This may be a realistic
limit for some allergen-derived peptides. We have previously
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shown that peptide fragments, as small as 2 kDa, have the
capacity to sensitize and elicit allergic reactions.10 In the present
study, we focus on examining under which conditions such
peptide fragments retain their allergenic potential.
The objective of this study was to increase our knowledge
and understanding of the allergenic capacity of small peptide
fragments. This was done by using the known major peanut
allergen Ara h 1 as a model allergen, based on the knowledge
that this allergen retains its allergenic potential when digested
to small peptide fragments while using pepsin as the enzyme for
digestion. Digestion products of Ara h 1 and fractions hereof
were thoroughly characterized, and examination of sensitizing
capacity was performed using a Brown Norway (BN) rat model
for food allergy.
■ MATERIALS AND METHODS
Purification of Peanut 7S Protein Ara h 1. Raw redskin peanuts
(Julian Graves LTD, Kingswinford, United Kingdom) were skin
peeled. Peanuts were frozen with liquid nitrogen and blended in a steel
blender until a fine texture was obtained. Subsequently, the crushed
peanuts were taken through two rounds of defatting [peanut:hexane,
1:5, w:v, 1 h, room temperature (RT)] and further homogenized in a
coffee grinder.
Proteins were extracted in double-distilled water (peanut:water, 1:5,
w:v) with 0.02% sodium azide (v:w), containing a protease inhibitor
tablet (Roche complete mini protease inhibitor tablet, Roche, Sussex,
United Kingdom) for 1 h at RT. After clarification by centrifugation
(3 000g, 20 min) ammonium sulfate was added to a saturation of 70%
and centrifuged (30 000g, 30 min). The supernatant was dialyzed
against buffer (Tris 20 mM, pH 7.5, 500 mM NaCl) at 4 °C, and
samples of 40 mL were applied to a column of 10 mL of Con A
Sepharose (GE Healthcare, Buckinghamshire, United Kingdom).
Unbound protein was removed by washing with the buffer, while
pure Ara h 1 was eluted by addition of 400 mM methyl α-D-
mannopyranoside. For further purity, eluted Ara h 1 was applied to a
column of Superdex 200 prep grade (HiLoad 16/60 and 26/60
Superdex 200 prep grade, GE Healthcare) and eluted with 25 mM
Tris, pH 7, and 150 mM NaCl. Purified Ara h 1 was filtrated through a
Millipore filter paper (0.22 μm, Millipore Corp., Bedford, MA) with
vacuum and afterward ultrafiltrated through an ultrafilter membrane
(pore size, 10 kDa) with gas (argon, 10 psi). The Ara h 1 was dialyzed
against 150 mM NaCl, and the concentration was determined by UV
absorbance reading at 280 nm. Furthermore, concentration of purified
Ara h 1 was determined by amino acid analysis to be 4.38 mg/mL. The
purified intact Ara h 1 was analyzed for the presence of endotoxin by
Lonza endotoxin testing service (Lonza, Verviers, Belgium).
N-Terminal Sequencing of Intact Ara h 1. To analyze the
isotype composition of intact Ara h 1, amino terminal sequencing was
performed. Protein sequencing of the intact Ara h 1 (5 μL, 16 pmol/μL)
was carried out by automated N-terminal Edman degradation in a Procise
494 sequencer (Applied Biosystems, Foster City, CA) in liquid phase
mode.
Simulated Gastric Digestion of Ara h 1. Gastric digestion was
performed essentially as described by Bøgh et al.10 In short, pepsin
immobilized to agarose (P0609, Sigma, St. Louis, MO) was washed
two times (100g, 1 min) in 10 mL of 1 mM HCl. Purified Ara h 1
(2.4 mg/mL in 150 mM NaCl) was adjusted to pH 2.5 with 1 M HCl
and added to the immobilized pepsin to yield an activity of pepsin of
approximately 170 U per mg Ara h 1. The solution was placed in a
shaking incubator (200 rpm, 37 °C) for 120 min. Reaction was
stopped by adjusting the pH to 7 with 1 M NaOH, centrifugation
(1 000g, RT, 2 min), and filtration of supernatant through a 0.45 μm
Millipore filter followed by a 0.22 μm filter.
Separation of Digested Ara h 1 into Fractions. For
fractionation of the digested Ara h 1, preparative gel permeation
chromatography (GPC) was performed. The digested Ara h 1 (6 mL,
2.3 mg/mL) was loaded onto a Superdex 75 prep grade, HiLoad
26/60 column (GE Healthcare, Uppsala, Sweden) connected to GradiFrac
system (Pharmacia Gradifrac FPLC system, GE Healthcare). Peptides
were eluted at RT with 150 mM NH4HCO3, pH 7.8, at 1 mL/min and
collected in fractions of 4 mL. The eluted peptides were detected by
absorbances at 280 and 226 nm. Four runs were made to fractionate all
digested Ara h 1. The column was calibrated for MW determination by
applying a standard mixture consisting of 1 mg/mL ferritin (440 kDa;
F4503, Sigma), 0.75 mg/mL ovotransferrin (79 kDa; C-0880, Sigma),
1 mg/mL carbonic anhydrase (29 kDa; C-3934, Sigma), 1 mg/mL
cytochrome C (14 kDa; C-2506, Sigma), 2 mg/mL apotinin (6 kDa;
A-1153, Sigma), and 0.1 mg/mL vitamin B12 (1.3 kDa; V-2876,
Sigma).
Fractions from the four consecutive runs were collected and pooled
according to the GPC profile (Figure 1) in three different pools
(in the following designated: digested Ara h 1, large complexes, and
small complexes), where digested Ara h 1 constitute the fraction of
large and small complexes. The pools were placed at −80 °C for a
minimum of 1 h, afterward freeze-dried for approximately 48 h, and
rediluted in Milli Q water [water drawn from a Milli Q System
equipped with an Organex cartridge from Millipore (Bedford, MA)] to
give a concentration of approximately 1 mg/mL.
Reverse Phase High-Performance Liquid Chromatography
(RP-HPLC) Analysis. For analysis of purity and residual intact Ara h 1
in the digests, analytical RP-HPLC was performed. Samples (40 μL, 1
mg/mL) were applied to a μRPC C2/C18 SC 2.1/10 column (120 Å
pore size, 3 μm particle size, 100 mm × 2.1 mm i.d., GE Healthcare)
connected to a SMART system (GE Healthcare). Chromatography
was performed at RT using 0.1% trifluoroacetic acid (TFA) in Milli Q
water (v:v) as solvent A and 0.1% TFA in Milli Q water:acetonitrile
(ACN) (10:90, v:v) as solvent B. Elution was performed at a flow rate
of 200 μL/min for 2.5 min with 5% solvent B, followed by elution with
a linear gradient of increasing concentration of solvent B from 5 to
50% for 22 min. Elution profiles were monitored using UV absorbance
at 220 and 280 nm. Fractions of 100 μL were collected, dried in a
vacuum centrifuge, and rediluted in 3 μL of Milli Q water for analysis
by matrix-assisted laser desorption/ionization time-of-flight (MALDI-
TOF) mass spectrometry (MS).
Amino Acid Analysis. For examination of amino acid composition
and quantification, amino acid analysis was performed according to
Barkholt and Jensen32 after hydrolysis overnight in HCl.
Figure 1. Preparative GPC of Ara h 1 digests. For fractionation of the
Ara h 1 digest, preparative GPC was performed in 150 mM
HN4HCO3, where Ara h 1 digest was separated into fractions based
on the chromatographic profile. From the profile, shown with
absorbances at 226 and 280 nm, it was decided to make three
different pools, indicated by the vertical dashed lines. The pools are
referred to as: digested Ara h 1, large complexes and small complexes,
where digested Ara h 1 is the whole pool of digest, consisting of both
the fraction of large and the fraction of small complexes. The first
double peak had an apparent MW of 60−440 kDa, indicating that
some intact Ara h 1 could be left in this fraction. To avoid the possible
presence of any intact Ara h 1 in the digests, this double peak was
excluded.
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MALDI-TOF MS. For analysis of peptide mass distribution in
samples of Ara h 1 digests, MALDI-TOF MS was performed on a
Bruker MALDI-TOF MS (MALDI TOF/TOF, Ultraflex II, Bruker
Daltonik GmbH, Bremen, Germany) equipped with pulsed ion
extraction and 200 Hz Smart Beam laser. One microliter of the
rediluted fractions from RP-HPLC was loaded onto a MALDI target,
followed by addition of 1 μL of 2% TFA and 1 μL of α-cyano-4-
hydrocinnamic acid [5 μg/μL in 70% ACN (v:v), 0.1% TFA (v:v)]. All
mass spectra were initially calibrated with a tryptic digest of
β-lactoglobulin.
GPC Analysis. For analysis of aggregation profiles in samples of
Ara h 1 digests, analytical GPC was performed. Samples (40 μL, 1 mg/mL)
were applied to a Superdex 75 PC 3.2/30 column (GE Healthcare)
connected to a SMART system (GE Healthcare). Chro-
matography was performed at RT with a flow rate of 50 μL/min
using 150 mM HN4HCO3 (pH 7.8) as the eluent. The eluent profiles
were monitored using UV absorbances at 220 and 280 nm. The
column was calibrated for MW using 12 μL of the standard mixture
previously described.
Animals. BN rats were from the in-house breeding colony at the
National Food Institute (DTU, Denmark), weaned at 3 weeks of age
and then housed in macrolon cages (two per cage) with a 12 h
light:dark cycle, at 22 ± 1 °C and 55 ± 5% relative humidity. Rats were
observed twice daily, and clinical signs were recorded.
Rats were kept on diet free from leguminous fruit for three
generations to avoid tolerance against Ara h 1. Rat diet was produced
in-house and based on rice flour, potato protein, and fish meal as
protein sources, as previously described,10 with the exception of maize
flakes being substituted with rice flour. Diet and acidified water were
given ad libitum. Animal experiments were carried out at the National
Food Institute (DTU, Denmark) facilities under conditions approved
by the Danish Animal Experiments Inspectorate and the in-house
Animal Welfare Committee.
Animal Sensitization Experiment. To study the sensitization
capacity of intact Ara h 1, digested Ara h 1 and fractions of the
digested Ara h 1, BN rats, 5−8 weeks of age, were allocated into five
groups of 8−12 animals. Rats were immunized ip with PBS (control),
200 μg of intact Ara h 1, 200 μg of digested Ara h 1, or 200 μg of
either the large or the small complexes, with the use of Alhydrogel 2%
in PBS as adjuvant. Rats were immunized three times, at days 0, 14,
and 28, and sacrificed at day 35 by exsanguination using carbon
dioxide inhalation as anesthesia. For further details, see Bøgh et al.10
Enzyme-Linked Immunosorbent Assays (ELISAs) for the
Detection of Specific IgG1, IgG2a, and IgE. ELISAs were
performed as previously described.10 Specific IgG1 and IgG2a were
detected by direct binding of antibodies to plate-coated antigens, while
IgE was detected in an antibody-capture ELISA, where Ara h 1 was
coupled to digoxigenin.
Curve Calculations and Statistical Analysis. Curve calculations
(XY analyses) and statistical calculations were made using GraphPad
Prism version 5.00 (GraphPad Software, San Diego, CA). ELISA re-
sults expressed as antibody titers were examined for group differences,
using the nonparametric one-way ANOVA, Kruskal−Wallis test,
followed by Dunn's multiple comparison test for comparison of three
or more groups. Differences between animal groups were regarded as
significant when P ≤ 0.05. Asterisks indicate a statistically significant
difference between the given group and the control group. Asterisks
over a horizontal line indicate a statistically significant difference
between the two given groups: * = P ≤ 0.05, ** = P ≤ 0.01, and *** =
P ≤ 0.001
■ RESULTS
Characteristics of Purified Ara h 1. From N-terminal
sequencing of the purified Ara h 1, it was evident that both
known isoforms of Ara h 1 were present, in the ratio of
approximately 1:1 (data not shown). The sequences identified
were RHPPGER and RSPPGER, demonstrating that the
purified isoforms of Ara h 1 start at amino acid residue 79
(RHPPGER, Ara h 1, clone P17, SwissProt no. P43237) or 85
(RSPPGER, Ara h 1, clone P41B, SwissProt P43238), a
confirmation of a study by Wichers et al.,33 showing that Ara h
1 is expressed as a truncated protein, in which the first 78 and
84 amino acids, respectively, are cleaved off. The endotoxin
analysis of the purified intact Ara h 1 was <2 endotoxin units
(EU)/mg of Ara h 1. From RP-HPLC analysis (Figure 2A), Ara
h 1 was calculated to be >98% pure.
Characteristics of Digested Ara h 1 and Fractions
Hereof. From RP-HPLC analyses, it was evident that no
residual intact Ara h 1 was left in the three pools of Ara h 1
digests, since no detectable peak at the elution time for intact
Ara h 1 was seen in the chromatography profiles (Figure 2A vs
B−D). When comparing the RP-HPLC profiles for digested
Ara h 1, large complexes and small complexes (Figure 2B−D),
no significant differences are shown, indicating no apparent
variation in peptide composition. However, when comparing
Figure 2. Analytical RP-HPLC. Comparison of chromatography profiles performed with 0.1% TFA/ACN for intact Ara h 1 (A), digested Ara h 1
(B), large complexes (C), and small complexes (D), shown with absorbances at 280 and 220 nm.
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the total amino acid distribution of the peptides present in the
three different pools (Figure 3), it was revealed that differences
did exist. While the amino acid distribution of digested Ara h 1
represented the amino acid distribution for intact Ara h 1, the
large complexes and the small complexes were found to have an
amino acid distribution different from that of the intact Ara h 1.
That digested Ara h 1 had an amino acid distribution similar to
the distribution of intact Ara h 1 confirms that this pool
contains a peptide composition representative of the intact
Ara h 1, where hydrophobic amino acids are responsible for
approximately 40%, the polar for approximately 12%, and the
charged for approximately 48% of total amino acids. In contrast,
the large complexes contain approximately 35% hydrophobic
amino acids, approximately 9% polar, and approximately 56%
charged amino acids, while the small complexes contain
approximately 48% hydrophobic amino acids, approximately
15% polar, and approximately 37% charged amino acids. This
shows that peptides constituting the two fractions of digested
Ara h 1 are different from each other and thereby different from
the whole pool of digested Ara h 1 and, therefore, do not
contain peptides representing the intact Ara h 1.
For examination of the peptide mass distribution profiles of
the three different pools of Ara h 1 digests, MALDI-TOF MS
was performed and demonstrated that Ara h 1 was digested to
small peptide fragments of sizes ≤ Mr 4 000 (Figure 4), of
which more than 75% had apparent Mr between 500 and 2 000.
As in the whole pool of digested Ara h 1, the peptides in the
large complexes had sizes up to Mr 4 000, while in the small
complexes, the peptides were ≤ Mr 3,000. So while the digested
Ara h 1 and the fraction of large complexes contained peptides
that were up to 33 amino acids, the longest peptides in the
fraction of small complexes were up to 25 amino acids.
However, for all three pools of Ara h 1 digests, by far, most
peptides were between 4 and 16 amino acids.
Realizing from the preparative GPC profile (Figure 1), based
on which the fractions of Ara h 1 digests were made that the
peptides were in some kind of aggregated state, we analyzed in
more detail the aggregation profiles of the three different pools.
From the analytical GPC profiles shown in Figure 5, it is
evident that the peptides in all three pools were indeed
aggregated into complexes of larger sizes. However, from the
profiles, it is revealed that the state of aggregation is very
different for the three different pools. From the area under the
220 nm GPC absorbance curves, it was indicated that 25% of
the peptides in digested Ara h 1 were aggregated into com-
plexes of up to Mr 104 000, that 53% of the peptides in the
large complexes were aggregated into complexes of up toMr 56
000, and that 7% of the peptides in the small complexes were
aggregated into complexes of up to Mr 9 000. So, depending on
the peptide composition profiles of the digested Ara h 1 and
fractions hereof, the aggregation profiles differed significantly.
See Table 1 for a summary of protein-chemical characteristics
of the three different pools of Ara h 1 digests.
Sensitizing Capacity of Digested Ara h 1 and
Fractions Hereof. Sera from individual BN rats dosed with
either PBS (control), 200 μg of intact Ara h 1, 200 μg of
digested Ara h 1, 200 μg of large complexes, or 200 μg of small
complexes were evaluated for specific antibodies against both
intact Ara h 1, digested Ara h 1, and fractions hereof. Looking
at the antibody response, it was evident that while both intact
Ara h 1 and whole pool of digested Ara h 1 could induce
specific IgG response, neither the large complexes nor the small
complexes could induce specific IgG antibodies. Analyses of the
specific IgG1 (Figure 6) and IgG2a, which revealed similar
Figure 3. Amino acid frequency distribution. Comparison of the amino acid distribution for intact Ara h 1 (A), digested Ara h 1 (B), large complexes
(C), and small complexes (D). The bars represent the frequency percentage of the indicated amino acid(s), represented by their one letter code, for
either the intact Ara h 1 or all peptides represented in the different pools of Ara h 1 digests. Amino acids are grouped according to their
physicochemical features.
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results (data not shown), showed that antibodies raised against
intact Ara h 1 were able to recognize both intact Ara h 1,
digested Ara h 1, and both fractions of the digested Ara h 1,
all to a statistically significant level. Although it is seen from
Figure 6 that all animals immunized with intact Ara h 1 could
react with all four samples of allergens, it is seen that the
binding capacity was different (although not statistically
significantly). IgG1 antibodies from the rats immunized with
intact Ara h 1 had the highest binding capacity toward the
intact Ara h 1, followed by the whole pool of digested Ara h 1
and then the fraction of large complexes. The lowest binding
capacity was toward the fraction of small complexes. Contrary
to antibodies raised against intact Ara h 1, the antibodies raised
against the whole pool of digested Ara h 1 could only react with
intact Ara h 1 and the whole pool of digested Ara h 1, the latter
being the only one that was statistically significant. The specific
antibody responses showed no statistically significant differ-
ences between rats immunized with intact and digested Ara h 1.
From Figure 7, it is seen that both intact and digested Ara h 1
could induce specific IgE, although the intact Ara h 1-specific
IgE response was only significant for antibodies raised against
intact Ara h 1. However, no statistically significant difference
was seen between rats immunized with intact and digested
Ara h 1, respectively, by use of a multiple comparison test.
Because it was not possible to couple the small peptide
fragments in digested Ara h 1 to a coupling protein, which
could be detected by commercially available secondary
antibodies, we could not determine digested Ara h 1-specific
IgE responses. We anticipate, however, that the specific IgE
response of rats immunized with digested Ara h 1 would be
higher for digested Ara h 1 than the one shown for intact Ara h 1.
These speculations are based on our knowledge that specific IgE
follows the specific IgG1 and IgG2a.10,34
■ DISCUSSION
The present study confirms that Ara h 1 retains both the
sensitizing and the reacting potential, when digested to small
peptide fragments. This signifies that digestion of Ara h 1 is not
an effective approach for significant reduction of neither
sensitizing nor IgE binding capacity and manifest that a
correlation between resistance to digestion and allergenicity
is not a general parameter. While Ara h 1 does not need to
survive the digestion process as an intact protein or as large
fragments to react with the immune system for induction of
a specific immune response, this could still be the case for
other food allergens. Previous studies examining the
influence of digestion on the allergenic potential of other
Figure 4. Peptide mass frequency distribution. Mass spectra of di-
gested Ara h 1 (A), large complexes (B), and small complexes (C),
shown in a histogram, where each bar corresponds to a peptide size
interval of 0.5 kDa.
Figure 5. Analytical GPC. Comparison of chromatography profiles
performed in 150 mM NH4HCO3 for digested Ara h 1 (A), fraction of
large complexes (B), and fraction of small complexes (C), shown
with absorbances at 280 and 220 nm. Standard MW markers
for absorbances at 280 and 220 nm are shown across the top of
the graph.
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food proteins have revealed digestion to be an effective
approach for a significant impairment of sensitization35,36
and IgE-binding capacity.35,37,38
We have previously shown that mixtures of peptides smaller
than 2−5 kDa, which was generally thought to be the lower size
limit for a peptide with inherent sensitizing capacity,31 may still
act as a “complete” allergen,39 being able to sensitize, elicit
allergic reaction, and react with IgE. The aim of this study was
to further examine how small peptides retain their sensitizing
capacity. This was done by studying the specific antibody
responses in BN rats immunized with digested Ara h 1 and
fractions hereof, separated on the basis of the aggregation
profile of the peptides.
From the GPC analysis of the digested Ara h 1, it was evident
that peptides did aggregate into complexes of larger sizes. This
may be a result of noncovalent interactions, like hydrophobic
interactions, since the single cysteine residue present in the Ara
h 1 molecule cannot account for the amount and sizes of the
complexes. That the sensitizing capacity of digested Ara h 1 is a
result of the peptide fragments forming aggregates was
hypothesized in earlier studies.9,10 That aggregation may
enhance the immune response toward antigen subunits was
already recognized in 1978, where Morein et al.40 showed that
aggregation of subunits by hydrophobic interactions induced a
significant higher immune response as compared to free
subunits, suggesting an importance of multimeric structures.
The same has been shown with the allergen melittin, a bee
venom protein of 2.8 kDa (26 amino acids), with one B cell
epitope41 and one T cell epitope.42 Melittin was able to induce
specific IgG and IgE responses in humans and animals. The
immunogenicity and allergenicity of the melittin were found to
correlate with oligomerization of the molecules.43−45 Also, the
state of aggregation may influence the way in which proteins
are presented to the immune system in the gastrointestinal
tract. This was indicated in a study by Roth-Walter et al.,46
which showed that aggregation of proteins from milk inhibited
their uptake by intestinal epithelial cells and redirected uptake
to Peyer's patches, promoting a significantly higher Th2-
associated antibody response. This supports the theory that
aggregation is a plausible explanation for the allergenic potential
of digested Ara h 1.
It is well recognized that small peptides in general are poor
immunogens and that peptides in general need to be of a
certain size to behave as sensitizing allergens. Muller31 stated
that it is commonly assumed that peptides in the range of 2−5
kDa behave like haptens and are not immunogenic. It is known
that for a protein to induce an allergic response, it requires the
presence of both T and B cell epitopes. However, immunization
with free peptides as small as 6−14 amino acid residues long
has been reported to induce acceptable antibody re-
sponses.31,47,48 This is in concordance with the earlier study
of sensitizing capacity of digested Ara h 1, where peptides of
less than 2 kDa were able to induce a statistically significant
antibody response without the use of additional adjuvant.10
This may indicate that the sensitizing capacity of digested Ara h
1 could also be an intrinsic feature of the free peptides
themselves. It has been shown several times that induction of
antibodies does not require covalent linkage between the
Table 1. Overview of Protein-Chemical Characteristics of the Different Pools of Ara h 1 Digests
amino acid distribution (%) aggregation profile
pool of digested Ara h 1 hydrophobic polar charged peptide sizes (Mr) amount (%) sizes (Mr)
digested Ara h 1 40 12 48 ≤4 25 104 000
fraction of large complexes 35 9 56 ≤4 53 56 000
Fraction of small complexes 48 15 37 ≤3 7 9 000
Figure 6. Specific IgG1 response. Comparison of specific IgG1 titer
values, for groups of rats immunized with either PBS (control), intact
Ara h 1, digested Ara h 1, large complexes, or small complexes. In each
group of rats, IgG1 antibodies were examined for their binding to both
intact Ara h 1, digested Ara h 1, the fraction of large complexes, and
the fraction of small complexes. Each symbol represents an individual
rat. Horizontal bars indicate the median value for each group of rats.
The statistically significant difference between the groups was
determined using Kruskal−Wallis test followed by Dunn's multiple
comparison test. Asterisks indicate statistically significant difference of
the given allergen-dosed group as compared with the control group for
the given specificity (represented by identical symbols).
Figure 7. Specific IgE response against intact Ara h 1. Comparison of
Ara h 1-specific IgE titer values, for groups of rats, immunized with
either PBS (control), intact Ara h 1, digested Ara h 1, large complexes,
or small complexes. Each symbol represents the specific IgE titer
response toward intact Ara h 1 for an individual rat. Horizontal bars
indicate median values. Statistically significant differences between
groups of rats were determined using Kruskal−Wallis test followed by
Dunn's multiple comparison test. Asterisks indicate statistically
significant difference of the given allergen-dosed group as compared
with the control group, and asterisks over a horizontal line indicate a
statistically significant difference between the two given allergen-dosed
groups.
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peptide behaving as T cell epitope and the peptide behaving as
B cell epitope.49−52 It has also been shown that amino acid
sequences that did not function as an antibody epitope when
part of a larger peptide were able to function as an antibody
epitope when presented as free small peptides in mixtures with
other peptides.47,49 This is consistent with the present study
showing that antibodies raised in rats immunized with the
whole pool of digested Ara h 1 had higher binding capacity
toward the digested Ara h 1 than toward the intact, indicating
that new epitopes that were not accessible in the intact Ara h 1
became accessible when digested to small peptides. These
results indicate that poor immunogenicity of peptides can be
overcome by coimmunization with mixtures of the peptides.
To further elucidate why digested Ara h 1 retained the
sensitizing potential, BN rats were immunized with fractions of
the digest. Strikingly, this study showed that by separating the
peptides of digested Ara h 1 into two fractions, the sensitizing
capacity was lost. While only a small part of the peptides in the
fraction of small complexes did aggregate, more than half of the
peptides in the fraction of large complexes were in aggregates of
sizes up to Mr 56 000. This is a larger part than in the whole
pool of digested Ara h 1 where only 25% of the peptides
aggregated. This reveals that allergenicity of the digested Ara h
1 is not simply a result of the peptides aggregating. The given
fact that aggregated complexes in the digested Ara h 1 was up
to Mr 104 000, nearly twice the size of the largest aggregates in
the large complexes, indicates that the aggregation profile
changed by means of fractionation in GPC. Instead of the
sensitizing capacity being simply a result of aggregation of the
peptides, the present study indicates that sensitization depends
on the way the peptides do aggregate. A possible explanation
may be that the aggregated peptides in the digested Ara h 1 are
in an architecture representing the natural configuration of
intact Ara h 1, while the peptides in the large complexes are in a
state of de novo aggregation. Epitopes have been classified as
either linear or conformational,53,54 and it is believed that most
B cell epitopes are conformational.39,55,56 However, for food
allergens, it has been suggested that linear epitopes could be of
importance, since the protein is presented to the mucosal
immune system of the gastrointestinal tract as denatured and
digested protein fragments, favoring a B cell response toward
linear sequences of amino acids.57,58 Indeed, linear IgE-binding
epitopes have been identified for various food allergens.58
Nevertheless, linear IgE-binding epitopes have been found to
contribute only a little to the total IgE binding,53,54,56,59 and no
biochemical characteristics were found to be shared between
the linear IgE-binding epitopes.58
If sensitizing potential of digested Ara h 1 is an intrinsic
feature of the free peptides themselves, however, coimmuniza-
tion with B and T cell epitopes does not explain why the
digested Ara h 1 retained sensitizing capacity, while this
sensitizing capacity was abolished when the peptides were
separated into fractions. An explanation could be that the
stability of digested Ara h 1 by some means was changed when
the peptides were separated. From amino acid analysis, it is
evident that when the peptides of digested Ara h 1 were
separated by GPC, the amino acid distribution was significantly
changed, leaving most charged peptides in the fraction of large
complexes and most hydrophobic peptides in the fraction of
small complexes. Consequently, the same peptides may
possibly not be present in the two different fractions and
certainly not to the same extent. That the type and amount of
peptides are of importance has been shown in several studies of
peptide vaccine development. Mixtures of peptides have been
shown to induce more B cell epitopes than did the very same
peptides when fused or administered alone,47,49,51,60 indicating
that peptides may function as adjuvant or in a synergistic way.
Accordingly, the present study suggests that most peptides in
the digest need to be present to serve as adjuvant augmenting
the immune response against other peptides and therefore need
to be administered together. In addition, it has been
demonstrated that peptides representing different T cell
epitopes varied significantly in their ability to provide help to
B cells. This suggests that the inherent property of the peptides
constituting T cell epitope peptides differ in efficacy and that
this feature may be independent of the protein from where they
origin.51,52
The present study revealed that different requirements are
needed for a protein to retain sensitizing and antibody binding
capacity. While the fractions of digested Ara h 1 had no
sensitizing potential, both fractions retained reactivity with
antibodies raised in rats immunized with intact Ara h 1. This
shows that there are larger requirements for peptides to
sensitize than for the peptides to retain reacting activity. These
results seem reasonable, since reacting activity only needs an
amino acid sequence resembling an antibody epitope, while
sensitizing capacity requires the ability to be recognized by the
immune system de novo, priming of specific B cells as well as
activation of T cells, providing the additional help needed for
proper differentiation and proliferation of antibody secreting
plasma cells. If most B cell epitopes of Ara h 1 are
conformational, this leaves us to explain how antibodies
directed against intact Ara h 1 are able to react with peptides
from the small complexes. Peptides in the small complexes do
not aggregate to an extent where they could represent
conformational epitopes but must instead be epitopes derived
from the linear sequence of the allergen. Aalberse39 states that
the main factor is the huge difference in binding affinity
between antibodies interacting with intact protein versus
interacting with peptides from the very same protein. This
means that the peptides are much less efficient as compared to
the intact protein for antibody binding. The peptide may for
instance represent only a fraction of the epitope39,54 or may
only be a mimic of the epitope for which the antibody was
originally directed against,53 with only a certain degree of
resemblance. The strength of interaction with the peptide could
be decreased even more because of the higher flexibility of free
peptides as compared to the complete protein.39 This is in
agreement with our own unpublished data, demonstrating a
higher avidity between the binding of antibodies and intact
protein as compared to the binding of the antibodies and
digests. It is suggested that about 10% of antibodies directed
toward conformational epitopes are able to react with linear
peptide fragments of the protein,53,54,56 which correlates well
with the present study.
In summary, the current study showed that while digested
Ara h 1 has sensitizing capacity, this capacity was lost after
separation of the peptides in the digest into fractions. The
sensitizing capacity of the digest was not dependent on single
peptides but rather the sum of peptides. However, to unravel if
the sensitizing capacity is a result of mixtures of free peptides or
is a result of the peptides being in a defined aggregated state,
further studies are needed. On the basis of the present study,
we may conclude that the way in which the digests are
presented to the immune systems is of significant importance
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for the outcome and confirms the complexity of the
mechanisms involved in sensitization.
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